Financial reports
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
17 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
Regulation FD Disclosure
24 Apr 24
8-K
Other Events
15 Apr 24
8-K
Departure of Directors or Certain Officers
26 Feb 24
8-K
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
30 Jan 24
8-K
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
18 Jan 24
8-K
Departure of Directors or Certain Officers
12 Jan 24
8-K
Entry into a Material Definitive Agreement
2 Jan 24
8-K
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
14 Dec 23
8-K
The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study
7 Dec 23
8-K
Other Events
30 Nov 23
Registration and prospectus
424B3
Prospectus supplement
25 Apr 24
424B3
Prospectus supplement
16 Apr 24
424B3
Prospectus supplement
4 Apr 24
S-1/A
IPO registration (amended)
1 Apr 24
S-1
IPO registration
20 Feb 24
424B3
Prospectus supplement
30 Jan 24
S-1/A
IPO registration (amended)
22 Jan 24
S-1
IPO registration
12 Jan 24
424B3
Prospectus supplement
2 Jan 24
S-3/A
Shelf registration (amended)
30 Nov 23
Proxies
DEFA14A
Additional proxy soliciting materials
19 Sep 23
DEF 14A
Definitive proxy
19 Sep 23
DEFA14A
Additional proxy soliciting materials
8 Aug 22
DEF 14A
Definitive proxy
8 Aug 22
DEFA14A
Additional proxy soliciting materials
18 Aug 21
DEF 14A
Definitive proxy
18 Aug 21
DEF 14A
Definitive proxy
31 Jul 20
DEF 14A
Definitive proxy
9 Aug 19
PRE 14A
Preliminary proxy
30 Jul 19
DEFR14A
Revised proxy
27 Jul 18
Other
EFFECT
Notice of effectiveness
4 Apr 24
EFFECT
Notice of effectiveness
26 Jan 24
CORRESP
Correspondence with SEC
23 Jan 24
UPLOAD
Letter from SEC
19 Jan 24
EFFECT
Notice of effectiveness
5 Dec 23
CORRESP
Correspondence with SEC
1 Dec 23
UPLOAD
Letter from SEC
1 Dec 23
EFFECT
Notice of effectiveness
18 Jul 23
UPLOAD
Letter from SEC
14 Jul 23
CORRESP
Correspondence with SEC
14 Jul 23
Ownership